These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22135069)

  • 21. [Acute coronary syndromes].
    Elbaz M; Roncalli J
    Rev Prat; 2008 Sep; 58(14):1527-37. PubMed ID: 18839681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The year in cardiology 2015: acute coronary syndromes.
    Montalescot G; Crea F
    Eur Heart J; 2016 Jan; 37(3):221-8. PubMed ID: 26726042
    [No Abstract]   [Full Text] [Related]  

  • 23. CardioPulse: 'Ten Commandments' of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS).
    Roffi M; Patrono C
    Eur Heart J; 2016 Jan; 37(3):208. PubMed ID: 27471758
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute coronary syndromes: a Canadian perspective.
    Fitchett DH
    Can J Cardiol; 2011; 27 Suppl A():S385-6. PubMed ID: 22118041
    [No Abstract]   [Full Text] [Related]  

  • 25. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance.
    Hill RA; Chung H; George E; Longson C; Stevens A
    Heart; 2010 Sep; 96(17):1407-8. PubMed ID: 20801857
    [No Abstract]   [Full Text] [Related]  

  • 26. [Indications for urgent coronary angiography. Part I: ST-segment elevation acute coronary syndromes].
    Iglesias JF; Roguelov C; Kabir T; Vogt P; Eeckhout E
    Rev Med Suisse; 2009 May; 5(205):1195-6, 1198-201. PubMed ID: 19517751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction.
    Cannon CP
    Crit Pathw Cardiol; 2010 Jun; 9(2):55-81. PubMed ID: 20520214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency department treatment of acute coronary syndromes.
    Yiadom MY
    Emerg Med Clin North Am; 2011 Nov; 29(4):699-710, v. PubMed ID: 22040701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
    Gutierrez A; Rao SV
    Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.
    Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT
    Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 33. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 34. Introduction. Key issues surrounding the treatment of acute coronary syndromes (ACS).
    Gibson CM; Watkins B; Merlo K
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S1-2. PubMed ID: 19090931
    [No Abstract]   [Full Text] [Related]  

  • 35. GP IIb-IIIa inhibitors administered upstream: evidence for improved outcomes with conventional and newer antithrombotic agents?
    Tricoci P; Newby LK
    Cardiol Rev; 2008; 16(2):89-94. PubMed ID: 18281911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial treatment of acute coronary syndromes. Is there a future for MONA acronym after the 2010 guidelines?
    Nikolaou NI; Vrints CJ
    Resuscitation; 2012 Jan; 83(1):e7. PubMed ID: 21982924
    [No Abstract]   [Full Text] [Related]  

  • 37. [ESC guidelines 2015. Non-ST-elevation acute coronary syndrome].
    Jobs A; Thiele H;
    Herz; 2015 Dec; 40(8):1027-33. PubMed ID: 26545604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.
    Mariani M; Mariani G; De Servi S
    Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual quality improvement in acute coronary syndromes: a performance improvement initiative.
    Cannon CP; Hoekstra JW; Larson DM; Mencia WA; Cornish J; Carter RD; Berry CA; Karcher RB
    Crit Pathw Cardiol; 2009 Mar; 8(1):43-8. PubMed ID: 19258838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.
    Elbarouni B; Elmanfud O; Yan RT; Fox KA; Kornder JM; Rose B; Spencer FA; Welsh RC; Wong GC; Goodman SG; Yan AT
    Am Heart J; 2010 Sep; 160(3):420-7. PubMed ID: 20826248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.